Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| JCNRX Fund | USD 30.60 0.17 0.56% |
Slightly above 52% of Janus Contrarian's investor base is interested to short. The analysis of overall sentiment of trading Janus Trarian Fund mutual fund suggests that many investors are impartial at this time. Janus Contrarian's investing sentiment can be driven by a variety of factors including economic data, Janus Contrarian's earnings reports, geopolitical events, and overall market trends.
Janus |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
Janus Contrarian Fundamental Analysis
We analyze Janus Contrarian's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Janus Contrarian using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Janus Contrarian based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Janus Trarian is currently under evaluation in probability of bankruptcy among similar funds. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Janus Contrarian Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Janus Contrarian mutual fund to make a market-neutral strategy. Peer analysis of Janus Contrarian could also be used in its relative valuation, which is a method of valuing Janus Contrarian by comparing valuation metrics with similar companies.
Peers
Janus Contrarian Related Equities
| JDCRX | Janus Forty | 0.76 | ||||
| JCNIX | Janus Contrarian | 0.59 | ||||
| JCNAX | Janus Contrarian | 0.56 | ||||
| JCONX | Janus Contrarian | 0.56 | ||||
| JCNCX | Janus Contrarian | 0.53 |
Other Information on Investing in Janus Mutual Fund
Janus Contrarian financial ratios help investors to determine whether Janus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Janus with respect to the benefits of owning Janus Contrarian security.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |